Pharmaceutical companies organize correspondent business training and collection.
Release time:
2020-08-17
Pharmaceutical Company Organized Correspondents Business Training and Collection
News In order to further strengthen the construction of pharmaceutical company correspondents and improve the writing and reporting level of grassroots correspondents, 7# May 10 , the Party Committee of Pharmaceutical Company organized more than 50 correspondents from pharmaceutical departments and subordinate enterprises to participate in news writing related knowledge training, anhui New North Card, Tianjin Flanders and other foreign enterprises through the video conference system to participate simultaneously.
This training invited Director He Chengming of Jinhua Daily to give lectures. The content includes general news and professional news, five elements of news, news authenticity, news habits, news genre, how to write good news, news stories, etc. Mr. He Chengming also explained through the events of Zhou Xiaoguang, deputy to the National People's Congress, village director of "Sankuai " , and Wang Jicai, the guardian of the island, that news must be true and true has vitality. The training content is easy to understand, not only news theory, but also news practice, news hot spots, as well as the characteristics of peak news reports. After the training of
, the pharmaceutical company also organized correspondents in Jin to go to Jinxi factory area of Jianfeng pharmaceutical factory to carry out collective gathering activities. Everyone visited the production sites such as raw material workshop, powder injection workshop, comprehensive preparation workshop, warehouse raw and auxiliary materials storage area, sewage treatment station, etc. The heads of each workshop department introduced the workshop facilities and equipment, technological process, operation process, characteristics and curative effect of main products, name of warehouse raw and auxiliary materials, principle and measures of waste water and waste gas treatment, etc. Zheng Kunwu, director ofPharmaceutical Factory, explained in detail the division of production areas, general situation of the enterprise, main products, production lines of each workshop, on-site management, formulation of production plan, whole-process inspection of central laboratory, intelligent control of sewage treatment, safety assessment, labor discipline assessment, formulation of department assessment, implementation and punishment of management, etc. of the pharmaceutical factory, and played the corporate promotional film of Jianfeng Pharmaceutical. Ni Zhenyu, the production department, explained the contents of visual standardization and work standardization in pharmaceutical factories. This gathering also gave the correspondents an in-depth understanding of the production site, enterprise operation, assessment and management mechanism of Jianfeng Pharmaceutical Factory.
After the collective gathering is over, the pharmaceutical company also requires each correspondent to write a training thought, carry out writing practice, and conduct evaluation. (Zhang Zhijian)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page